david david dodell subject medical news part cut limit azt efficacy suggest use drug either sequentially drug kind aid treatment cocktail combine number drug fight virus treat people azt alone doe happen real world anymore say dr mark jacobson university california san francisco also recent find indicate hiv replicate rapidly lymph node infection physician may begin push even harder early treatment hiv-infected patient new infectious disease push american medical news vol p center disease control launch worldwide network track spread infectious disease detect drug-resistant new strain time help prevent spread network expect cost million million essential part clinton administration health reform plan accord cdc outside expert plan require cdc enhance surveillance disease unite state establish facility across world track disease april nih plan begin aid drug trial earlier stage nature vol p macilwain colin hicnet medical newsletter page volume number april national institute health ha announce start treat hiv-positive patient soon possible seroconversion result recent find show hiv active body large number much earlier wa previously believe anthony fauci director national institute allergy infectious disease niaid say must address question treat people early possibly drug safe enough give people year get around microbial resistance say delay would signify question safety resistance rather lack fund fauci co author one two paper publish last week nature reject argument one co-author cecil fox new discovery indicate billion spend vaccine trial ha waste time money trial start long patient infect end quickly john tew medical college virginia richmond claim new evidence strongly back argument early treatment hiv-infected patient aid activist welcome new information say scientific community ha slow understand significance infection lymph tissue know five year glad public domain say jesse dobson california-based project inform peter duesberg belief aid independent hiv result drug abuse west say several paradox away explanation aid even paper right april risk aid virus doctor find minimal washington post p risk hiv transmit infect health-care professional patient minimal accord new research publish today journal american medical association jama find support previous conclusion health expert chance contract hiv health care worker remote three study jama demonstrate thousand patient treat two hiv-positive surgeon dentist without become infect virus study conduct separate research team new hampshire maryland florida study start hiv-positive doctor dentist test patient participate new hampshire study find none patient undergo invasive procedure hiv-positive orthopedic surgeon contract hiv maryland patient operate breast surgery specialist john hopkins hospital find hiv-negative similarly florida dental hicnet medical newsletter page volume number april patient treat hiv-positive general dentist test find negative hiv florida researcher lead gordon dickinson university miami school medicine say study indicate risk transmission hiv general dentist patient minimal set universal precaution strictly observe relate story philadelphia inquirer p alternative medicine advocate divide new nih research program aid treatment news p gilden dave new office alternative medicine national institute health ha raise question nih commitment effort us unorthodox holistic therapeutic method oam small division nih budget million dollar compare billion nih whole addition money available research grant even smaller total available year grant kaiya montaocean center natural traditional medicine washington say oam afraid become involve aid look successful easy answer aid say also common perception oam focus field nih establishment find non-threatening relaxation technique acupuncture oam call advisory committee conference people last year aid community wa largely miss meet addition activist general lack contact office ha add suspicion epidemic ignore jon greenberg york say oam advisory panel compose practitioner without real research experience take several year accept nature research nevertheless dr leanna standish research director aid investigator bastyr college naturopathic medicine seattle say wonderful opportunity fund aid research fair give office time gel public insist much much public relation herpesvirus decimate immune-cell soldier science news vol p fackelmann kathy scientist conduct test tube experiment find herpesvirus attack human immune system natural killer cell attack cause killer cell malfunction diminish important component immune system fight disease also may factor immune disease aid paolo lusso research find attack another white cell t-lymphocyte primary target hiv lusso also find hicnet medical newsletter page volume number april kill natural killer cell scientist previously know natural killer cell patient infect hiv work correctly lusso research represent first time scientist indicate natural killer cell vulnerable kind viral attack accord anthony l komaroff researcher harvard medical school despite test-tube find scientist uncertain whether result occur body lusso team also find produce receptor molecule provide access hiv t-lymphocytes express surface receptor make vulnerable hiv attack researcher conclude cell exacerbate affect hiv april aid priority global village editor journal american medical association vol p gellert george nordenberg dale f health-care worker obligate responsible ensure politician understand dimension certain health problem also commit relate policy write george gellert dale f nordenberg orange county health care agency santa ana calif emory university school public health atlanta ga respectively dr berkley editorial american doctor care aid epidemic beyond unite state detail several reason concert interest country share combat aid note aid lead hasten global health interdependence illness disease malaria many respiratory intestinal pathogen similarly inhibit economic development humanity act marginalize large population berkley mention enormous social economic impact aid many develop country increase need international assistance result berkley also cite lack political aggressiveness toward aid epidemic first decade new administration promise substantial difference approach international health development general particular vice president al gore propose book earth balance major environmental initiative include sustainable international development program promote literacy improve child survival disseminate contraceptive technology access throughout develop world enact change policy could drastically change future worldwide health aid priority global village reply journal american hicnet medical newsletter page volume number april medical association vol p berkley seth every nation tackle hiv early aggressively possible disease reach endemic state even cost divert le attention illness write seth berkley rockefeller foundation new york reply letter drs gellert nordenberg although true disease aid malaria respiratory intestinal illness similarly inhibit economic development develop country deserve much attention get berkley disagree contention aid receive much attention hiv differ disease develop country continue spread endemic disease outcome neglect intervention one year another year level needle disease death aid increase spread cost neglect disease burden financially much greater intervention early part rampantly spread epidemic like hiv highly cost-effective individual infection prevent significantly interrupt transmission berkley say agree gellert nordenberg gigantic social economic effect aid need political leadership conclude assertive political leadership need unite state aid epidemic even develop country high rate hiv infection complacency epidemic ha rule hicnet medical newsletter page volume number april article first hiv vaccine trial begin hiv-infected child h h n e w department health human service march first hiv vaccine therapy trial begin hiv-infected child national institute health ha open first trial experimental hiv vaccine child infect human immunodeficiency virus hiv virus cause aid trial compare safety three hiv experimental vaccine child recruit least site nationwide volunteer must hiv infect symptom hiv disease hhs secretary donna e shalala say initial study see hopeful milestone effort ameliorate tragedy hiv-infected child face certainty develop aid anthony fauci director national institute allergy infectious disease nih office aid research say trial first step find whether vaccine help prevent delay disease progression child hiv yet sick vaccine prove safe sophisticate question therapeutic potential assess phase ii trial center disease control prevention estimate child unite state hiv end decade world health organization project million child infect worldwide study enroll child age month year old niaid fund aid clinical trial group network anticipate conduct trial nine actg site around country three site participate actg fund national institute child health human development preliminary evidence similar study way infect adult show certain vaccine boost exist hiv-specific immune response hicnet medical newsletter page volume number april stimulate new one several year however researcher know response affect clinical course disease result pediatric trial know actg examine closely reason well trial provide first insight immature immune system respond candidate hiv vaccine say daniel hoth director niaid division aid need information design trial test whether experimental vaccine prevent hiv infection child unite state hiv-infected child live poor inner-city area percent minority mainly black hispanic nearly hiv-infected child acquire virus mother pregnancy birth infect mother unite state ha one four chance transmit virus baby grow number woman childbearing age become expose hiv injection drug use infect sexual partner researcher expect correspond increase number infect child hiv disease progress rapidly infant child adult recent information suggest percent infant bear hiv develop serious aids-related infection year age infection include severe frequent bout common bacterial illness childhood result seizure pneumonia diarrhea symptom lead nutritional problem long hospital stay least half child trial year age younger enable comparison immune response younger older participant volunteer must well-documented hiv infection symptom hiv disease swell lymph gland mildly swell liver spleen receive anti-retroviral immune regulate drug within one month prior entry study study chair john lambert university rochester medical school co chair samuel katz duke university school medicine coordinate trial assist jam mcnamara medical officer pediatric medicine branch niaid division aid compare safety vaccine closely monitor child side effect see one vaccine produce swell arm fever example another say dr mcnamara also look whether low high vaccine stimulate immune response significant laboratory clinical effect emphasize small study size preclude compare response effect among three hicnet medical newsletter page volume number april product trial test two three experimental vaccine make recombinant hiv protein so-called subunit vaccine genetically engineer contain piece virus far prove well tolerate ongoing trial hiv-infected adult one vaccine make microgenesys inc meriden conn contain protein give rise hiv surface protein plus alum adjuvant adjuvant boost specific immune response vaccine presently alum adjuvant use human vaccine license food drug administration vaccine one make genentech inc south san francisco biocine joint venture chiron ciba-geigy emeryville calif contain major hiv surface protein plus adjuvant genentech vaccine contain alum biocine vaccine contain experimental adjuvant ha prove safe effective phase vaccine trial adult low dose product test first placebo child twelve child assign random immunize experimental vaccine three child give adjuvant alone consider placebo neither health care worker child tell receive low dose well-tolerated control test higher dose experimental vaccine adjuvant placebo another group child begin child receive six immunization one every four week six month followed-up week last immunization information trial site eligibility enrollment call aid clinical trial information service est weekday service ha spanish-speaking information specialist available information niaid pediatric research available office communication nih cdc fda agency public health service hhs press inquiry please call laurie k doepel hicnet medical newsletter page volume number april new evidence hiv cause disease independently news national institute dental research new evidence human immunodeficiency virus cause disease independently ability suppress immune system say scientist national institues health report hiv opportunistic infection cause scale skin condition develop mouse carry gene hiv although hiv gene active mouse compromise animal immunity researcher find lead conclude hiv cause skin disease find support grow body evidence hiv cause disease without affect immune system say lead author dr jeffrey kopp national institute dental research nidr dr kopp colleague describe study march issue aid research human retrovirus develop animal model hiv infection ha difficult since animal include mouse infect virus bypass problem scientist develop hiv-transgenic mouse carry gene hiv well genetic material nidr scientist create transgenic mouse inject hiv gene mouse egg implant egg female mouse result litter contain normal transgenic animal institute scientist create mouse carry complete copy hiv genetic material mouse however become sick die soon birth study depth present study scientist use incomplete copy hiv allow animal live longer transgenic animal develop scale wart-like tumor neck back transgenic mouse develop thicken crust skin lesion cover body resemble psoriasis human skin lesion develop normal non-transgenic littermates study tissue take wart-like skin tumor show type noncancerous tumor call papilloma although papillomavirus cause skin lesion laboratory test show sign virus animal tissue sample take sick mouse throughout study reveal presence protein-producing molecule make hiv genetic material hicnet medical newsletter page volume number april evidence hiv protein production prove viral gene turn active say dr kopp scientist find evidence however compromise immunity mouse increase white blood cell count sign common infection fact hiv gene active animal immune system suppress confirm virus wa cause skin lesion dr kopp say proof hiv gene involvement come test scientist expose transgenic animal ultraviolet light light increase hiv genetic activity cause papilloma develop formerly healthy skin papilloma formation response increase hiv genetic activity prove gene responsible skin condition scientist say lesion appear normal mouse expose uv light transgenic mouse use study develop nidr dr peter dickie national institute allergy infectious disease collaborate study dr kopp mr charles wohlenberg drs nickolas dorfman joseph bryant abner notkins paul klotman nidr dr stephen katz national cancer institute dr jam rooney formerly nidr burroughs wellcome hicnet medical newsletter page volume number april clinical consultation telephone service aid h h n e w department health human service march hhs secretary donna e shalala today announce first nationwide clinical consultation telephone service doctor health care professional question provide care people hiv infection aid toll-free national hiv telephone consult service staff physician nurse practitioner pharmacist provide information drug clinical trial latest treatment method service fund health resource service administration operate san francisco general hospital secretary shalala say one goal project share expertise patient get best care second goal get primary health care provider involve care people hiv aid reduce treatment cost allow patient remain medical provider community social support network currently many provider refer patient hiv aid specialist provider experience secretary shalala say clinical expertise especially helpful physician provider treat people hiv aid community clinical site hiv expertise readily available telephone number health care professional accessible est pst monday friday time consultant try answer question immediately within hour time physician health care provider leave electronic message question answer quickly possible health care professional may call service ask question relate provide hiv care include latest drug treatment information clinical trial information subspecialty case referral literature search information service design health care professional rather patient family others alternate source information material health care professional call new service call take either clinical pharmacist primary care physician family nurse practitioner staff member extensive experience outpatient inpatient primary care people hiv-related disease consultant ask patient-specific information include cell count current medication sex age patient hiv history national service ha grow local effort hicnet medical newsletter page volume number april respond nearly call health care provider northern california initial project wa fund hrsa bureau health profession community provider aid train cpat project american academy family physician provider expand knowledge also improve quality care able provide patient say hrsa administrator robert g harmon project great resource health care professional patient serve service ha open new mean communication health care professional expert hiv care management say hrsa associate administrator aid director bureau health resource development g stephen bowen provider treat people hiv aid access latest information new drug treatment method therapy people hiv aid hrsa one eight public health service agency within hhs aid hotline number consumer cdc national aid hotline information spanish aid clinical trial english spanish hicnet medical newsletter page cut last part internet david fax bitnet asuacad fidonet amateur packet 